[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Abbott Laboratories (ABT) - Financial and Strategic SWOT Analysis Review

November 2021 | 102 pages | ID: A1CD28CAA41EN
GlobalData

US$ 125.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Abbott Laboratories (ABT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Abbott Laboratories (Abbott) discovers, develops, manufactures and sells a diversified range of healthcare products including branded generic pharmaceuticals, diagnostic systems and tests, and pediatric and adult nutritional products. The company also offers various medical devices including heart failure, electrophysiology, rhythm management, vascular and structural heart devices, and neuromodulation devices. The company also offers minerals and nutrition products and various dietary supplements. It has research and development facilities in the US, China, Colombia, India, Singapore, Spain, and the UK; and operates manufacturing facilities across the world. The company markets products in North America, Latin America, the Middle East, Europe, Asia-Pacific and Africa. Abbott is headquartered in Abbott Park, Illinois, the US.

Abbott Laboratories Key Recent Developments

Nov 23,2021: Abbott launches NeuroSphere Virtual Clinic in UK
Nov 10,2021: New research finds challenges in symptom recognition and diagnostic testing can impact patient satisfaction for people with vascular disease
Nov 03,2021: Abbott launches new initiative to drive diversity in medical research and improve care among under-represented populations
Oct 20,2021: Abbott reports third-quarter 2021 results; Achieves strong double-digit earnings growth and raises guidance
Sep 30,2021: Abbott commits to reducing malnutrition globally with launch of Abbott Center for Malnutrition Solutions

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Abbott Laboratories - Key Facts
Abbott Laboratories - Key Employees
Abbott Laboratories - Key Employee Biographies
Abbott Laboratories - Major Products and Services
Abbott Laboratories - History
Abbott Laboratories - Company Statement
Abbott Laboratories - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Abbott Laboratories - Business Description
Business Segment: Diagnostic Products
Overview
Performance
Key Stats
Business Segment: Established Pharmaceutical Products
Overview
Performance
Business Segment: Medical Devices
Overview
Performance
Key Stats
Business Segment: Nutritional Products
Overview
Performance
Key Stats
Business Segment: Others
Performance
Geographical Segment: All Other Countries
Performance
Geographical Segment: China
Performance
Geographical Segment: Germany
Performance
Geographical Segment: India
Performance
Geographical Segment: Japan
Performance
Geographical Segment: Switzerland
Performance
Geographical Segment: The Netherlands
Performance
Geographical Segment: United States
Performance
R&D Overview
Abbott Laboratories - Corporate Strategy
Abbott Laboratories - SWOT Analysis
SWOT Analysis - Overview
Abbott Laboratories - Strengths
Abbott Laboratories - Weaknesses
Abbott Laboratories - Opportunities
Abbott Laboratories - Threats
Abbott Laboratories - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Abbott Laboratories, Medical Equipment, Deals By Year, 2015 to YTD 2021
Abbott Laboratories, Medical Equipment, Deals By Type, 2015 to YTD 2021
Abbott Laboratories, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Nov 10, 2021: New research finds challenges in symptom recognition and diagnostic testing can impact patient satisfaction for people with vascular disease
Nov 03, 2021: Abbott launches new initiative to drive diversity in medical research and improve care among under-represented populations
Oct 20, 2021: Abbott reports third-quarter 2021 results; Achieves strong double-digit earnings growth and raises guidance
Sep 30, 2021: Abbott commits to reducing malnutrition globally with launch of Abbott Center for Malnutrition Solutions
Aug 30, 2021: Abbott Laboratories announces Patricia P. Gonzalez as Board of Director
Jul 23, 2021: Abbott records 39.5% rise in sales for Q2 2021
May 18, 2021: Addressing high blood pressure to reduce health disparities in central Texas underserved communities
May 16, 2021: No benefit to FFR-guided PCI in STEMI patients with multi-vessel disease
Apr 21, 2021: Abbott’s sales increase 35.3% in first quarter
Apr 06, 2021: CSols announces a joint webinar with Abbott Informatics highlighting an innovative STARLIMS configuration

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Abbott Laboratories, Key Facts
Abbott Laboratories, Key Employees
Abbott Laboratories, Key Employee Biographies
Abbott Laboratories, Major Products and Services
Abbott Laboratories, History
Abbott Laboratories, Other Locations
Abbott Laboratories, Subsidiaries
Abbott Laboratories, Key Competitors
Abbott Laboratories, Ratios based on current share price
Abbott Laboratories, Annual Ratios
Abbott Laboratories, Annual Ratios (Cont...1)
Abbott Laboratories, Annual Ratios (Cont...2)
Abbott Laboratories, Interim Ratios
Abbott Laboratories, Medical Equipment, Deals By Year, 2015 to YTD 2021
Abbott Laboratories, Medical Equipment, Deals By Type, 2015 to YTD 2021
Abbott Laboratories, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Abbott Laboratories, Performance Chart (2016 - 2020)
Abbott Laboratories, Ratio Charts
Abbott Laboratories, Medical Equipment, Deals By Year, 2015 to YTD 2021
Abbott Laboratories, Medical Equipment, Deals by Type, 2015 to YTD 2021


More Publications